Cleared Traditional

K983031 - VITROS IMMUNODIAGNOSTIC PRODUCTS AFP ASSAY

K983031 is the FDA 510(k) clearance for VITROS IMMUNODIAGNOSTIC PRODUCTS AFP ASSAY by Ortho-Clinical Diagnostics, Inc.. It is a Class 2 Immunology device (product code LOJ) cleared through the Traditional 510(k) pathway after a 109-day FDA review.

K983031 · Ortho-Clinical Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1998
Decision
109d
Days
Class 2
Risk

K983031 is an FDA 510(k) clearance for the VITROS IMMUNODIAGNOSTIC PRODUCTS AFP ASSAY. Classified as Kit, Test,alpha-fetoprotein For Testicular Cancer (product code LOJ), Class II - Special Controls.

Submitted by Ortho-Clinical Diagnostics, Inc. (Rochester, US). The FDA issued a Cleared decision on December 18, 1998 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.6010 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ortho-Clinical Diagnostics, Inc. devices

Submission Details

510(k) Number K983031 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 1998
Decision Date December 18, 1998
Days to Decision 109 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 104d · This submission: 109d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LOJ Kit, Test,alpha-fetoprotein For Testicular Cancer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.6010
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LOJ Kit, Test,alpha-fetoprotein For Testicular Cancer

All 12
Devices cleared under the same product code (LOJ) and FDA review panel - the closest regulatory comparables to K983031.
ST AIA-PACK AFP ENZYME IMMUNOASSAY
K023894 · Tosoh Medics, Inc. · Dec 2002
ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY
K020806 · Bayer Corp. · Mar 2002
DSL ACTIVE AFP ELISA, MODEL DSL-10-8400
K990138 · Diagnostic Systems Laboratories, Inc. · Jun 1999
IMMULITE AFP, MODEL LKAPI, LKAP5, IMMULITE 2000 AFP, MODEL L2KAP2
K983263 · Diagnostic Products Corp. · Dec 1998
ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER MODEL NUMBER 33211
K981354 · Beckman Instruments, Inc. · May 1998
ELECSYS AFP
K973351 · Boehringer Mannheim Corp. · Nov 1997